We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRWV:NASDAQCoreWeave, Inc. Analysis

Data as of 2026-05-19 - not real-time

$103.77

Latest Price

8/10Risk

Risk Level: High

Executive Summary

CoreWeave trades around $103.8, roughly half of the DCF‑derived fair value of $211.8, implying a potential upside of more than 100% and a 36% upside relative to consensus targets. Revenue is booming at a 111% year‑over‑year growth rate with a robust 69% gross margin, yet the company posts a -25.6% profit margin, a negative forward P/E of -151, and a free cash flow deficit of $8.6 bn, underscored by a staggering debt‑to‑equity ratio above 730. Volatility is extreme, with a 30‑day swing of 87.8% and a beta of 2.8, reflecting a highly leveraged, high‑growth profile in a hot AI‑infrastructure niche.
Technically, the stock sits below its 20‑day SMA of $116 and the 50‑day SMA of $99.8, with a bearish MACD histogram and an RSI hovering at 44.9, indicating neutral momentum but no immediate upside momentum. Support sits near $98.7 while resistance is around $138.3, and volume is on the rise, suggesting market interest. Recent news highlights sizable contracts with major players like Meta, the rollout of the SUNK self‑service platform, and analyst upgrades to $149‑$156 price targets, reinforcing the long‑term growth thesis despite short‑term price pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day SMA and bearish MACD histogram
  • Neutral RSI indicating limited upside momentum
  • Recent 12% price dip creating a potential entry point but uncertainty remains

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth exceeding 100% and strong gross margins
  • Analyst price‑target upgrades to $149‑$156
  • Expanding AI infrastructure contracts and new SUNK platform rollout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamental AI‑infrastructure demand tailwinds
  • DCF fair value indicating substantial upside
  • Strategic positioning with high‑performance GPU compute for AI workloads

Key Metrics & Analysis

Financial Health

Revenue Growth111.60%
Profit Margin-25.57%
P/E Ratio-151.4
ROE-40.67%
ROA-0.22%
Debt/Equity738.54
P/B Ratio15.6
Op. Cash Flow$6.0B
Free Cash Flow$-8560327168
Industry P/E38.2

Technical Analysis

TrendNeutral
RSI44.9
Support$98.65
Resistance$138.25
MA 20$116.05
MA 50$99.81
MA 200$100.30
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$211.85
Target Price$141.32
Upside/Downside36.19%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.83
Volatility87.76%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.